Is case-mix adjustment necessary for an expanded dialysis bundle?

Health Care Financing Review

Volumn 24, Issue 4, 2003, Pages 77-88

  Hirth, Richard A ^a   Wolfe, Robert A ^b   Wheeler, John R C ^b   Roys, Erik C ^b   Tedeschi, Philip J ^b   Pozniak, Alyssa S ^b   Wright, Glenn T ^b  

^a UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CASE MIX; CLINICAL FEATURE; DEMOGRAPHY; DIAGNOSTIC PROCEDURE; DIALYSIS; FATALITY; FEMALE; GOVERNMENT; HEALTH CARE COST; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICARE; PRESCRIPTION; PROSPECTIVE PAYMENT;

ADOLESCENT; ADULT; AGED; DIAGNOSTIC SERVICES; DRUG COSTS; HEALTH CARE COSTS; HUMANS; KIDNEY FAILURE, CHRONIC; MEDICARE; MIDDLE AGED; PROSPECTIVE PAYMENT SYSTEM; RENAL DIALYSIS; RISK ADJUSTMENT; UNITED STATES;

EID: 0141885159     PISSN: 01958631     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Ashby, V.B., Wolfe, R.A., Loos, M.E., and Port, F.K: The Effect of Comorbidities on Facility Standardized Mortality Ratios. Journal of the American Society of Nephrology 9:197a. 1998.
2. Dor, A., Held, P., and Pauly, M.: The Medicare Cost of Renal Dialysis: Evidence from a Statistical Cost Function. Medical Care 30(10):879-891, October 1992.
3. Federal Register: Vol. 64, No. 146, 41690-41696 (July 30, 1999).
4. Forum of ESRD Networks Clearinghouse Office. Summary Report of the End Stage Renal Disease (ESRD) Network's Annual Reports, 2000. Internet address: http://cms.hhs.gov/esrd/2c.pdf
5. Hirth, R., Held, P., Orzol, S., and Dor, A., Changing Treatment Patterns, Practice Patterns, Case-Mix, Medicare Payment Policy and Dialysis Facility Costs. Health Services Research 33(6):1567-1592, February 1999.
6. Hynes, D.M., Stroupe, K.T., Greer, J.W., et al.: Potential Cost Savings of Erythropoietin Administration in End-Stage Renal Disease. American Journal of Medicine 112(3):169-175, February 2002.
7. Longenecker, J.C., Klag, M.J., Levey, A.S., et al.: Validation of Comorbid Conditions on the End Stage Renal Disease Medical Evidence Report: The CHOICE Study. Journal of the American Society of Nephrology 11:520-529, 2000.
8. Medicare Payment Advisory Commission: Report to the Congress: Medicare Payment Policy. MedPAC. Washington, DC. March 2002.
9. Roys, E.C., Port, F.K., Agodoa, L.Y.C., et al.: Validation of Medical Evidence Form with DMMS Data Showing Relative Importance as Predictor of Mortality. Journal of the American Society of Nephrology 10: 255a, 1999.
10. U.S. Renal Data System: USRDS 1999 Annual Data Report. National Institutes of Heath, National Institute of Diabetes and Digestive and Kidney Diseases. Bethesda, MD. April 1999.
11. University of Michigan Kidney Epidemiology and Cost Center: Guide to the 2002 Unit-Specific Reports for Dialysis Patients: Overview, Methodology, and Interpretation. April 2002. Internet address: http://www.med.umich.edu/kidney/usr/facguide.pdf. (Accessed 2003.)
12. Wolfe, R.A., Ashby, V.B., and Port, F.K.: 1993 DMMS Comorbidity Index Validated by Medical Evidence Form Data. Journal of the American Society of Nephrology 11: 1300a, 2000.